文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HIV 暴露前预防污名量表的验证:李克特量表和语义差异量表版本的表现。

Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions.

机构信息

Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA.

Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA.

出版信息

AIDS Behav. 2020 Sep;24(9):2637-2649. doi: 10.1007/s10461-020-02820-6.


DOI:10.1007/s10461-020-02820-6
PMID:32157490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7423865/
Abstract

Stigma regarding HIV pre-exposure prophylaxis (PrEP) is commonly implicated as a factor limiting the scale-up of this highly effective HIV prevention modality. To quantify and characterize PrEP stigma, we developed and validated a brief HIV PrEP Stigma Scale (HPSS) among a group of 279 men who have sex with men (MSM). Scale development was informed by a theoretical model to enhance content validity. We assessed two scale versions, Semantic Differential and Likert, randomizing the order in which scales were presented to participants. Both scales demonstrated high internal consistency. The Likert scale had substantially better construct validity and was selected as the preferred option. Scale scores demonstrated construct validity through association with constructs of interest: healthcare distrust, HIV knowledge, perceived proportion of friends/partners on PrEP, perceived community evaluation of PrEP, and perceived effectiveness of PrEP. The scale accounted for 25% of the total variance in reported willingness to be on PrEP, indicating the substantial role PrEP stigma may have on decisions to initiate PrEP. Given increased efforts to roll-out PrEP, having a valid tool to determine the level and types of PrEP stigma in individuals, groups, and communities can help direct implementation plans, identify goals for stigma reduction, and monitor progress over time.

摘要

艾滋病毒暴露前预防(PrEP)的污名通常被认为是限制这种高效艾滋病毒预防方式扩大规模的一个因素。为了量化和描述 PrEP 污名,我们在一组 279 名男男性行为者(MSM)中开发并验证了一种简短的艾滋病毒 PrEP 污名量表(HPSS)。量表的开发得到了一个理论模型的指导,以增强内容的有效性。我们评估了两种量表版本,语义差异和李克特,随机呈现量表给参与者的顺序。两种量表都显示出了很高的内部一致性。李克特量表具有更好的结构有效性,因此被选为首选。通过与感兴趣的结构的关联,量表得分表现出了结构有效性:对医疗保健的不信任、艾滋病毒知识、对朋友/伴侣中使用 PrEP 的比例的感知、对社区对 PrEP 的评价的感知以及对 PrEP 有效性的感知。该量表解释了报告愿意接受 PrEP 的意愿的 25%的总方差,表明 PrEP 污名可能对启动 PrEP 的决定有很大影响。鉴于扩大 PrEP 的推出,拥有一个有效的工具来确定个人、群体和社区中 PrEP 污名的程度和类型,可以帮助指导实施计划,确定减少污名的目标,并随着时间的推移监测进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5e/7423865/1e0ce86191af/10461_2020_2820_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5e/7423865/1e0ce86191af/10461_2020_2820_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5e/7423865/1e0ce86191af/10461_2020_2820_Fig1_HTML.jpg

相似文献

[1]
Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions.

AIDS Behav. 2020-9

[2]
The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.

AIDS Patient Care STDS. 2017-11-29

[3]
Development and Validation of the Community PrEP-Related Stigma Scale (Community-PSS).

AIDS Educ Prev. 2021-4

[4]
Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men.

AIDS Care. 2019-4

[5]
Experiences of Anticipated and Enacted Pre-exposure Prophylaxis (PrEP) Stigma Among Latino MSM in Los Angeles.

AIDS Behav. 2019-7

[6]
Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.

AIDS Behav. 2018-4

[7]
Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk.

J Int AIDS Soc. 2016-6-3

[8]
Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.

LGBT Health. 2016-2-9

[9]
Perceptions among Dutch men who have sex with men and their willingness to use rectal microbicides and oral pre-exposure prophylaxis to reduce HIV risk--a preliminary study.

AIDS Care. 2015

[10]
Pre-Exposure Prophylaxis (PrEP) Awareness and Acceptability Among Men Who Have Sex With Men in Taiwan.

AIDS Educ Prev. 2018-12

引用本文的文献

[1]
Investigating the potential accessibility to HIV pre-exposure prophylaxis via community pharmacies and sexual health clinics: a scoping review of two integrated care systems in London.

BMC Health Serv Res. 2025-7-1

[2]
Intimate Partner Violence Perpetration and PrEP Use Among Sexual Minority Men: The Mediating Roles of Internalized Homonegativity and PrEP Stigma.

AIDS Behav. 2025-6-24

[3]
Opinions and Concerns Surrounding Long-Acting Injectable (LAI) and Oral HIV Pre-exposure Prophylaxis (PrEP) Among Current and Former LAI and Oral PrEP Users.

AIDS Behav. 2025-6-17

[4]
PrEP knowledge, attitudes, and perceived barriers to access among American Indian/Alaska Native people in the US: Results from an online survey.

PLoS One. 2025-4-30

[5]
The Association Between Use of Adherence Support Interventions and Adherence to HIV Preexposure Prophylaxis Among Young South African and Zimbabwean Women in HPTN 082.

AIDS Behav. 2025-4-10

[6]
Improving Pre-Exposure Prophylaxis Provision as Part of Routine Gynecologic Care Among Black Cisgender Women (Project PrEP4Her): Protocol for the Implementation of an Intervention.

JMIR Res Protoc. 2025-3-14

[7]
Preference for HIV Pre-exposure Prophylaxis Access Among Men who Have Sex With Men in China: A Discrete Choice Experiment.

Open Forum Infect Dis. 2025-1-9

[8]
Novel Machine Learning HIV Intervention for Sexual and Gender Minority Young People Who Have Sex With Men (uTECH): Protocol for a Randomized Comparison Trial.

JMIR Res Protoc. 2024-8-20

[9]
Examining HIV pre-exposure prophylaxis (PrEP) acceptability among rural people who inject drugs: predictors of PrEP interest among syringe service program clients.

AIDS Care. 2024-12

[10]
Examining the Interplay Between Preexposure Prophylaxis (PrEP) and Gender-Related Stigmas as Barriers for PrEP Uptake Among Transgender Women in Tijuana, Mexico: A Mixed-Methods Study.

AIDS Behav. 2024-11

本文引用的文献

[1]
An Electronic Pre-Exposure Prophylaxis Initiation and Maintenance Home Care System for Nonurban Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.

JMIR Res Protoc. 2019-6-10

[2]
Clinic-Based Delivery of the Young Men's Health Project (YMHP) Targeting HIV Risk Reduction and Substance Use Among Young Men Who Have Sex with Men: Protocol for a Type 2, Hybrid Implementation-Effectiveness Trial.

JMIR Res Protoc. 2019-5-21

[3]
Contrasting Self-Perceived Need and Guideline-Based Indication for HIV Pre-Exposure Prophylaxis Among Young, Black Men Who Have Sex with Men Offered Pre-Exposure Prophylaxis in Atlanta, Georgia.

AIDS Patient Care STDS. 2019-3

[4]
The Annual American Men's Internet Survey of Behaviors of Men Who Have Sex With Men in the United States: 2016 Key Indicators Report.

JMIR Public Health Surveill. 2019-2-20

[5]
Adolescent Trials Network for HIV-AIDS Scale It Up Program: Protocol for a Rational and Overview.

JMIR Res Protoc. 2019-2-1

[6]
Experiences of Anticipated and Enacted Pre-exposure Prophylaxis (PrEP) Stigma Among Latino MSM in Los Angeles.

AIDS Behav. 2019-7

[7]
The Development and Testing of a Relationship Skills Intervention to Improve HIV Prevention Uptake Among Young Gay, Bisexual, and Other Men Who Have Sex With Men and Their Primary Partners (We Prevent): Protocol for a Randomized Controlled Trial.

JMIR Res Protoc. 2019-1-2

[8]
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

Lancet HIV. 2018-10-17

[9]
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Ann Epidemiol. 2018-6-22

[10]
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Ann Epidemiol. 2018-6-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索